Last updated on March 2020

A 5-year Longitudinal Observational Study of Patients Undergoing Therapy for IMISC


Brief description of study

TARGET-DERM is a 5-year, longitudinal, observational study of adult and pediatric patients being managed for Atopic Dermatitis and other Immune-Mediated Inflammatory Skin Conditions (IMISC) in usual clinical practice. TARGET-DERM will create a research registry of patients with IMISC within academic and community real-world practices in order to assess the safety and effectiveness of current and future therapies.

Clinical Study Identifier: NCT03661866

Find a site near you

Start Over

Johnson Dermatology

Fort Smith, AR United States
  Connect »

First OC Dermatology

Fountain Valley, CA United States
  Connect »

Forest Hills Dermatology Group

Forest Hills, NY United States
  Connect »

Windsor Dermatology

East Windsor, NJ United States
  Connect »

Houston Skin Associates

Webster, TX United States
  Connect »

Spokane Dermatology Clinic

Spokane, WA United States
  Connect »

Ohio State University

Columbus, OH United States
  Connect »

El Paso Dermatology Center

El Paso, TX United States
  Connect »

Mayo Clinic

Rochester, MN United States
  Connect »

Ichan School of Medicine

New York, NY United States
  Connect »

Center for Clinical Studies

Webster, TX United States
  Connect »

Allergy and Clinical Immunology

Pittsburgh, PA United States
  Connect »

Carl Thornblade, MD, PLLC

Missoula, MT United States
  Connect »

Advanced Allergy & Asthma, PLLC

Rockville Centre, NY United States
  Connect »

Asthma and Allergy Center

Lewisville, TX United States
  Connect »

George Washington University

Washington, WA United States
  Connect »